Two Phase 3 Trials of Baricitinib for Alopecia Areata. King B, Ohyama M, Kwon O, Zlotogorski A, et al. N Engl J Med 2022;386:1687-1699.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

King B, Ohyama M, Kwon O, Zlotogorski A, et al. Two Phase 3 Trials of Baricitinib for Alopecia Areata. N Engl J Med 2022;386:1687-1699.
PMID: 35334197